Stefan Oscarson News Today

Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) spin-out company, has raised $36m (€32.6m) in series A funding.

Founded by researchers based in UCD and San Francisco, Aer is developing a novel drug to help COPD patients breathe easier.

Company was co-founded by Irishman Prof John Fahy of University of California, San Francisco and Prof Stefan Oscarson of UCD

Aer Therapeutics, a joint University College Dublin and University of California, San Francisco biopharmaceutical spin-out company developing novel in....

Aer Therapeutics, a biopharmaceutical spin-out company has secured $36M (approximately €32.7M) in a Series A round of funding. 

Aer Therapeutics receives money from a syndicate of premier life science industry investors

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Aer Therapeutics, a biopharmaceutical company developing novel inhaled treatments for muco-obstructive lung diseases, today announced the...

Prof Stefan Oscarson and Prof Stephen Carrington won for developing a new drug for mucus-related issues for patients with lung conditions.

14 of the 29 new members being welcomed by the Royal Irish Academy this year are from STEM. We take a quick look at what they do.